TrianglePUBLICATIONS · 27439911
Carfilzomib significantly improves the progression-free survival of high-risk patients in multiple myeloma.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Blood
- Publication date
- 2016 Sep 1
- First author
- Avet-Loiseau H
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Avet-Loiseau H
- type
- Author
- name
- Fonseca R
- type
- Author
- name
- Siegel D
- type
- Author
- name
- Dimopoulos MA
- type
- Author
- name
- Špička I
- type
- Author
- name
- Masszi T
- type
- Author
- name
- Hájek R
- type
- Author
- name
- Rosiñol L
- type
- Author
- name
- Goranova-Marinova V
- type
- Author
- name
- Mihaylov G
- type
- Author
- name
- Maisnar V
- type
- Author
- name
- Mateos MV
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Avet-Loiseau H
- type
- Author
- name
- Fonseca R
- type
- Author
- name
- Siegel D
- type
- Author
- name
- Dimopoulos MA
- type
- Author
- name
- Špička I
- type
- Author
- name
- Masszi T
- type
- Author
- name
- Hájek R
- type
- Author
- name
- Rosiñol L
- type
- Author
- name
- Goranova-Marinova V
- type
- Author
- name
- Mihaylov G
- type
- Author
- name
- Maisnar V
- type
- Author
- name
- Mateos MV
- type
- Author
- bibliography ids
- nci-bib-11dc85f344207a9a42b7d20f
- book metadata
- content sha256
- 545c45fb4f543a468eee702355b20334a5d5932b2f79bd2b6a985f822f8711d5
- document type
- citation
- dois
- 10.1182/blood-2016-03-707596
- electronic publication date
- display
- 2016 Jul 20
- precision
- day
- year
- 2016
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:27439911
- immutable id
- pubmed:27439911@545c45fb4f543a468eee702355b20334a5d5932b2f79bd2b6a985f822f8711d5
- journal
- abbreviation
- Blood
- issn electronic
- 1528-0020
- issn print
- 0006-4971
- issue
- 9
- name
- Blood
- nlm unique id
- 7603509
- pages
- 1174-80
- volume
- 128
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 27439911
- provenance
- batch id
- d649bcb2d98dbbacd53c
- provider
- NCBI PubMed ESummary
- record sha256
- d29d859f7347a1e4c47227ac8567161090215f042d228623fb41a50ad449cb1d
- response sha256
- 26648a40f123f366675007f51cc29befd1f9a89273ca2da87c477c54d2d15d20
- retrieved at
- 2026-09-09T23:47:20.761544+00:00
- publication date
- display
- 2016 Sep 1
- precision
- day
- year
- 2016
- publication types
- Clinical Trial, Phase III
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Carfilzomib significantly improves the progression-free survival of high-risk patients in multiple myeloma.
Preserved source evidence · Not medical advice